» Articles » PMID: 17190813

N-formylation of Lysine in Histone Proteins As a Secondary Modification Arising from Oxidative DNA Damage

Overview
Specialty Science
Date 2006 Dec 28
PMID 17190813
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

The posttranslational modification of histone and other chromatin proteins has a well recognized but poorly defined role in the physiology of gene expression. With implications for interfering with these epigenetic mechanisms, we now report the existence of a relatively abundant secondary modification of chromatin proteins, the N(6)-formylation of lysine that appears to be uniquely associated with histone and other nuclear proteins. Using both radiolabeling and sensitive bioanalytical methods, we demonstrate that the formyl moiety of 3'-formylphosphate residues arising from 5'-oxidation of deoxyribose in DNA, caused by the enediyne neocarzinostatin, for example, acylate the N(6)-amino groups of lysine side chains. A liquid chromatography (LC)-tandem mass spectrometry (MS) method was developed to quantify the resulting N(6)-formyl-lysine residues, which were observed to be present in unperturbed cells and all sources of histone proteins to the extent of 0.04-0.1% of all lysines in acid-soluble chromatin proteins including histones. Cells treated with neocarzinostatin showed a clear dose-response relationship for the formation of N(6)-formyl-lysine, with this nucleosome linker-selective DNA-cleaving agent causing selective N(6)-formylation of the linker histone H1. The N(6)-formyl-lysine residue appears to represent an endogenous histone secondary modification, one that bears chemical similarity to lysine N(6)-acetylation recognized as an important determinant of gene expression in mammalian cells. The N(6)-formyl modification of lysine may interfere with the signaling functions of lysine acetylation and methylation and thus contribute to the pathophysiology of oxidative and nitrosative stress.

Citing Articles

The TRIM33 Bromodomain Recognizes Histone Lysine Lactylation.

Nunez R, Sidlowski P, Steen E, Wynia-Smith S, Sprague D, Keyes R ACS Chem Biol. 2024; 19(12):2418-2428.

PMID: 39556662 PMC: 11706526. DOI: 10.1021/acschembio.4c00248.


Cracking Lysine Crotonylation (Kcr): Enlightening a Promising Post-Translational Modification.

Westerveld M, Besermenji K, Aidukas D, Ostrovitsa N, Petracca R Chembiochem. 2024; 26(2):e202400639.

PMID: 39462860 PMC: 11776371. DOI: 10.1002/cbic.202400639.


Exploring Intrinsic Disorder in Human Synucleins and Associated Proteins.

Venati S, Uversky V Int J Mol Sci. 2024; 25(15).

PMID: 39125972 PMC: 11313516. DOI: 10.3390/ijms25158399.


The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy.

Yang Y, Zhang M, Wang Y J Natl Cancer Cent. 2024; 2(4):277-290.

PMID: 39036551 PMC: 11256729. DOI: 10.1016/j.jncc.2022.09.002.


Protein lysine crotonylation in cellular processions and disease associations.

Zhao H, Han Y, Zhou P, Guan H, Gao S Genes Dis. 2024; 11(5):101060.

PMID: 38957707 PMC: 11217610. DOI: 10.1016/j.gendis.2023.06.029.


References
1.
Bell S, Botting C, Wardleworth B, Jackson S, White M . The interaction of Alba, a conserved archaeal chromatin protein, with Sir2 and its regulation by acetylation. Science. 2002; 296(5565):148-51. DOI: 10.1126/science.1070506. View

2.
Zeng L, Zhou M . Bromodomain: an acetyl-lysine binding domain. FEBS Lett. 2002; 513(1):124-8. DOI: 10.1016/s0014-5793(01)03309-9. View

3.
Jaskelioff M, Peterson C . Chromatin and transcription: histones continue to make their marks. Nat Cell Biol. 2003; 5(5):395-9. DOI: 10.1038/ncb0503-395. View

4.
Hake S, Xiao A, Allis C . Linking the epigenetic 'language' of covalent histone modifications to cancer. Br J Cancer. 2004; 90(4):761-9. PMC: 2410168. DOI: 10.1038/sj.bjc.6601575. View

5.
Wang Y, Fischle W, Cheung W, Jacobs S, Khorasanizadeh S, Allis C . Beyond the double helix: writing and reading the histone code. Novartis Found Symp. 2004; 259:3-17. View